Daylight Forensic Partners with Lachman Consultants to Offer FCPA Counsel and Regulatory Compliance to Pharma and Medical Device Companies

Wednesday, December 16, 2009 Medical PDA News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 15 Daylight Forensic & Advisory, a leading regulatory advisory and investigative firm, announced today a new partnership with Lachman Consultant Services, a leader in advising pharmaceutical and medical device companies, to help companies deal with compliance issues, including the Foreign Corrupt Practices Act (FCPA).

Recent pronouncements by the United States Department of Justice to aggressively enforce and investigate violations of the FCPA, targeting pharmaceutical and medical device companies as well as their individual executives and board members, leaves them open to potentially massive legal and financial liabilities. The combined services of Daylight and Lachman can help companies who are concerned about FCPA liability proactively limit and manage their risk on these issues.

"We are proud to be joining with Lachman to provide consulting services to individuals and companies in the pharma and medical device industries," said Joseph Spinelli, Chief Operating Officer, Daylight Forensic & Advisory. "Companies operating in this space are learning that the DOJ is actively pursuing FCPA-related investigations and expect companies to begin taking steps to limit their fraud exposure and put adequate systems in place to avoid problems. The combined resources and expertise of Daylight and Lachman can help companies by ensuring they have an effective compliance program in place."

Daylight Forensic & Advisory has unparalleled FCPA and anti-corruption expertise. Daylight has developed and implemented enterprise level automated third party risk assessment and due diligence systems and programs, developed and implemented customized compliance training programs, conducted investigations, and assessed and enhanced compliance programs, including internal controls systems, for some of the world's largest companies.

Lachman Consultant Services, Inc. has exceptional knowledge and experience in all aspects of pharmaceutical and device compliance, regulatory, science and technology matters, covering discovery, development, filing and approval, manufacturing, distribution and post- marketing surveillance. Lachman works with global pharmaceutical and device firms to develop, implement, audit and remediate systems and controls for corporate compliance programs.

About Daylight Forensic & Advisory LLC

Daylight Forensic & Advisory LLC ( conducts forensic investigations and advises on regulatory compliance issues to financial services organizations, corporations and the public sector worldwide. Headquartered in New York City, with offices in Washington, Miami and London, the company is backed by FTV Capital, a private equity firm.

About Lachman Consultant Services, Inc.

The experience and reputation you can trust. Through a multidisciplinary team of industry, regulatory, and scientific specialists, Lachman Consultants ( helps organizations to prevent and resolve compliance problems and to develop efficient and effective strategies for compliance and for the submission and approval of drugs, biologics, dietary supplements, devices and allied health care items. The company deploys only highly experienced senior ex-industry and senior ex-FDA specialists who consistently deliver top quality results for a diverse base of global clients and the law firms that serve them and our regulatory advisory and investigative partner firm, Daylight Forensic & Advisory LLC. Lachman Consultant Services, Inc. is headquartered in Westbury, N.Y., and is privately owned.

For additional information: Daylight Forensic & Advisory Joe Spinelli (212) 554-2603, Scott Moritz (212) 554-2626 and Jay Perlman (202) 552-8407 Lachman Consultant Services Roy Sturgeon (516) 222-6222

SOURCE Daylight Forensic & Advisory LLC

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store